Title : Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant.

Pub. Date : 2017 Jun

PMID : 28630385






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Treatment by lenalidomide and pcDNA3.1(+)/NS3 improves NK cytotoxicity up to 66.80% suggesting that lenalidomide can be used in parallel with such therapeutic vaccines as cancer vaccine or virus vaccines. Lenalidomide KRAS proto-oncogene, GTPase Homo sapiens